DNA vaccines for emerging infectious diseases: what if?
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

DNA vaccines for emerging infectious diseases: what if?
  • Published Date:

    1996 Jul-Sep

  • Source:
    Emerg Infect Dis. 2(3):168-175.
Filetype[PDF-41.29 KB]


Details:
  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
  • Description:
    A novel and powerful method for vaccine research, colloquially known as DNA vaccines, involves the deliberate introduction into tissues of a DNA plasmid carrying an antigen-coding gene that transfects cells in vivo and results in an immune response. DNA vaccines have several distinct advantages, which include ease of manipulation, use of a generic technology, simplicity of manufacture, and chemical and biological stability. In addition, DNA vaccines are a great leveler among re-searchers around the world because they provide unprecedented ease of experi-mentation. To facilitate diffusion of information, an Internet site has been established called THE DNA VACCINE WEB (URL:http://www.genweb.com/dnavax/dnavax.html). In this review, a brief survey is undertaken of the experimental models and preclinical work on DNA vaccines to contribute to a greater awareness of the possibilities for emerging infectious diseases.
  • Document Type:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: